4D Molecular Therapeutics
FDMT
#7172
Rank
C$0.82 B
Marketcap
C$14.67
Share price
-4.57%
Change (1 day)
-4.02%
Change (1 year)

Earnings for 4D Molecular Therapeutics (FDMT)

Earnings in 2026 (TTM): -C$0.28 Billion

According to 4D Molecular Therapeutics's latest financial reports the company's current earnings are C$92 Million. In 2025 the company made an earning of -C$0.23 Billion, an increase over its 2024 earnings that were of -C$0.27 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for 4D Molecular Therapeutics from 2020 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -C$0.28 Billion20.98%
2025 -C$0.23 Billion-15.06%
2024 -C$0.27 Billion66.43%
2023 -C$0.17 Billion2.58%
2022 -C$0.16 Billion54.25%
2021 -C$0.11 Billion25.89%
2020 -C$81.27 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-C$0.23 Billion-20.79%๐Ÿ‡บ๐Ÿ‡ธ USA